Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 82 (RNA5SP82)
- Target
- RNA5SP82
- Molecular classification
- Pseudogene, 5S ribosomal RNA pseudogene, Long noncoding RNA (potential, based on general knowledge of pseudogene transcripts)
01
Overview
RNA, 5S ribosomal pseudogene 82 (RNA5SP82) is classified as a *pseudogene* in the human genome, most closely related to the 5S ribosomal RNA family. Pseudogenes are genomic sequences resembling functional genes but contain mutations or structural changes that prevent them from producing functional products. The RNA5SP82 locus does not encode a protein and is not known to be transcribed into a functional RNA species in human tissue. Like other ribosomal RNA pseudogenes, RNA5SP82 likely arose through gene duplication or retrotransposition and subsequent inactivation. While certain pseudogene transcripts can regulate gene expression or compete with parental gene transcripts, there is no evidence RNA5SP82 performs any biological function or is involved in disease. It is not considered a receptor, enzyme, transporter, or therapeutic target[1][2][3][6].
- Other names
- RN5S82RNA, 5S ribosomal 82RNA5SP82
02
Mechanism of action
Not applicable; no drugs target RNA5SP82 or its pseudogene class directly
03
Biological functions
None established specific to RNA5SP82General pseudogene functions may include regulation of gene expression by: Competing with parental gene for RNA-binding proteins (RBPs)Serving as decoys for regulatory RNAsGeneration of endogenous siRNAs or antisense transcripts, but functional data for RNA5SP82 specifically is lackingMost 5S ribosomal pseudogenes are non-coding and do not produce functional RNA
04
Disease associations
No direct disease association for RNA5SP82 as per available curated resourcesPseudogenes, as a general class, may be involved in cancer and other diseases through altered gene regulation; individual involvement depends on expression and interactionsNo specific evidence for RNA5SP82 in cancer or other pathologies
05
Safety considerations
Not relevant; not a therapeutic target and does not encode a functional protein
06
Interacting drugs
None known
07
Biomarkers
No evidence RNA5SP82 serves as a biomarker for any disease or drug responseSome pseudogenes have been identified as potential cancer biomarkers in expression profiling, but RNA5SP82 does not appear in these lists
Beyond the preview
Go deeper on RNA, 5S ribosomal pseudogene 82 (RNA5SP82).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 82 (RNA5SP82).